You are here
Home > Drugs > Helicobacter Pylori

Helicobacter pylori

First option (Preferred option): proton pump inhibitor (eg, lansoprazole 30 mg twice daily, omeprazole 20 mg twice daily, pantoprazole 40 mg twice daily, rabeprazole 20 mg twice daily, or esomeprazole 40 mg once daily) PLUS Biaxin 500mg orally twice daily PLUS  Amoxicillin 1 gram orally twice daily x 14 days.
Second option (penicillin allergic): proton pump inhibitor (eg, lansoprazole 30 mg twice daily, omeprazole 20 mg twice daily, pantoprazole 40 mg twice daily, rabeprazole 20 mg twice daily, or esomeprazole 40 mg once daily) PLUS  Biaxin 500mg orally twice daily PLUS  Flagyl 500mg orally twice daily x 14 days. 
Third option : proton pump inhibitor (eg, lansoprazole 30 mg twice daily, omeprazole 20 mg twice daily, pantoprazole 40 mg twice daily, rabeprazole 20 mg twice daily, or esomeprazole 40 mg once daily)  PLUS Pepto Bismol (2 tablets) orally four times daily  PLUS  flagyl 500mg orally three times daily for  14 days.
Dual therapy regimens using a PPI plus one antibiotic (amoxicillin or clarithromycin) are frequently cited in the literature. However, they cannot be recommended as primary therapy because their eradication rates are significantly lower (60 to 85 percent) than the standard regimens.
Combination products: Helidac (bismuth subsalicylate + metronidazole + Tetracycline).  PrevPac (lansoprazole + amoxicillin + clarithromycin)
 

Listed dosages are for - Adult patients ONLY.    PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. GlobalRPH does not directly or indirectly practice medicine or provide medical services and therefore assumes no liability whatsoever of any kind for the information and data accessed through the Service or for any diagnosis or treatment made in reliance thereon.

David F. McAuley, Pharm.D., R.Ph.
GlobalRPh Inc.

Reference(s)

National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates.  A local search option of this data can be found here.

Helicobacter Pylori